185 related articles for article (PubMed ID: 37415147)
1. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
[TBL] [Abstract][Full Text] [Related]
3. PARP1-siRNA suppresses human prostate cancer cell growth and progression.
Lai Y; Kong Z; Zeng T; Xu S; Duan X; Li S; Cai C; Zhao Z; Wu W
Oncol Rep; 2018 Apr; 39(4):1901-1909. PubMed ID: 29393407
[TBL] [Abstract][Full Text] [Related]
4. PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.
Pu J; Li T; Liu N; Luo C; Quan Z; Li L; Wu X
Oncol Rep; 2020 May; 43(5):1397-1412. PubMed ID: 32323799
[TBL] [Abstract][Full Text] [Related]
5. Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage.
Ding L; Zheng Q; Lin Y; Wang R; Wang H; Luo W; Lu Z; Xie H; Ren L; Lu H; Yu C; Zhang J; Shen D; Cheng S; Xia L; Li G; Xue D
Clin Transl Med; 2023 Jan; 13(1):e1156. PubMed ID: 36597139
[TBL] [Abstract][Full Text] [Related]
6. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer.
Köcher S; Beyer B; Lange T; Nordquist L; Volquardsen J; Burdak-Rothkamm S; Schlomm T; Petersen C; Rothkamm K; Mansour WY
Int J Cancer; 2019 Apr; 144(7):1685-1696. PubMed ID: 30478958
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer.
Du Z; Zhang F; Liu L; Shen H; Liu T; Jin J; Yu N; Wan Z; Wang H; Hu X; Chen Y; Cai J
BMC Cancer; 2023 Feb; 23(1):130. PubMed ID: 36755223
[TBL] [Abstract][Full Text] [Related]
8. PARP1 Is Targeted by miR-519a-3p and Promotes the Migration, Invasion, and Tube Formation of Ovarian Cancer Cells.
Chang H; Zhang X; Li B; Meng X
Cancer Biother Radiopharm; 2022 Nov; 37(9):824-836. PubMed ID: 34009012
[No Abstract] [Full Text] [Related]
9. Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter.
Tian YN; Chen HD; Tian CQ; Wang YQ; Miao ZH
Cell Death Dis; 2020 Jan; 11(1):71. PubMed ID: 31992690
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression.
Zhang Y; Huang J; Huang Y; Zhang S; Wu W; Long H; Duan X; Lai Y; Wu W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179075
[TBL] [Abstract][Full Text] [Related]
11. ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
Qu G; Zhang Y; Duan H; Tang C; Yang G; Chen D; Xu Y
Apoptosis; 2023 Jun; 28(5-6):783-795. PubMed ID: 36881291
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
13. Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.
Han S; Brenner JC; Sabolch A; Jackson W; Speers C; Wilder-Romans K; Knudsen KE; Lawrence TS; Chinnaiyan AM; Feng FY
Neoplasia; 2013 Oct; 15(10):1207-17. PubMed ID: 24204199
[TBL] [Abstract][Full Text] [Related]
14. RecQ helicase BLM regulates prostate cancer cell proliferation and apoptosis.
Qian X; Feng S; Xie D; Feng D; Jiang Y; Zhang X
Oncol Lett; 2017 Oct; 14(4):4206-4212. PubMed ID: 28943928
[TBL] [Abstract][Full Text] [Related]
15. C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2'-O-methylation of PARP1.
Lu B; Chen X; Liu X; Chen J; Qin H; Chen S; Zhao Y
J Transl Med; 2022 Dec; 20(1):618. PubMed ID: 36566215
[TBL] [Abstract][Full Text] [Related]
16. MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.
Tian S; Lou L; Tian M; Lu G; Tian J; Chen X
J Exp Clin Cancer Res; 2020 Jul; 39(1):143. PubMed ID: 32711558
[TBL] [Abstract][Full Text] [Related]
17. N
Chen B; Liu C; Long H; Bai G; Zhu Y; Xu H
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484368
[TBL] [Abstract][Full Text] [Related]
18. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
19. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.
Qin L; Sun X; Zhou F; Liu C
World J Surg Oncol; 2021 Jun; 19(1):184. PubMed ID: 34158077
[TBL] [Abstract][Full Text] [Related]
20. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
Wang ZY; Duan Y; Wang P
J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
